cbdMD, Inc. (YCBD)
0.3626
-0.01
(-2.74%)
USD |
NYAM |
Oct 23, 16:00
0.369
+0.01
(+1.77%)
After-Hours: 20:00
cbdMD Enterprise Value : 4.127M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.127M |
| October 22, 2026 | 4.241M |
| October 21, 2026 | 4.308M |
| October 20, 2026 | 4.402M |
| October 19, 2026 | 3.966M |
| October 16, 2026 | 4.054M |
| October 15, 2026 | 4.097M |
| October 14, 2026 | 4.020M |
| October 13, 2026 | 4.043M |
| October 12, 2026 | 4.056M |
| October 09, 2026 | 4.431M |
| October 08, 2026 | 4.485M |
| October 07, 2026 | 4.621M |
| October 06, 2026 | 4.632M |
| October 05, 2026 | 4.871M |
| October 02, 2026 | 5.166M |
| October 01, 2026 | 5.105M |
| September 30, 2026 | 5.132M |
| September 29, 2026 | 5.310M |
| September 28, 2026 | 5.249M |
| September 25, 2026 | 5.299M |
| September 24, 2026 | 5.199M |
| September 23, 2026 | 5.181M |
| September 22, 2026 | 5.655M |
| September 21, 2026 | 4.988M |
| Date | Value |
|---|---|
| September 18, 2026 | 5.100M |
| September 17, 2026 | 5.655M |
| September 16, 2026 | 5.277M |
| September 15, 2026 | 5.211M |
| September 14, 2026 | 5.400M |
| September 11, 2026 | 5.457M |
| September 10, 2026 | 5.410M |
| September 09, 2026 | 5.565M |
| September 08, 2026 | 5.652M |
| September 04, 2026 | 5.384M |
| September 03, 2026 | 5.444M |
| September 02, 2026 | 5.653M |
| September 01, 2026 | 5.654M |
| August 31, 2026 | 5.544M |
| August 28, 2026 | 5.655M |
| August 27, 2026 | 5.623M |
| August 26, 2026 | 5.878M |
| August 25, 2026 | 5.855M |
| August 24, 2026 | 5.522M |
| August 21, 2026 | 5.754M |
| August 20, 2026 | 5.711M |
| August 19, 2026 | 5.544M |
| August 18, 2026 | 5.321M |
| August 17, 2026 | 5.377M |
| August 14, 2026 | 5.608M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tilray Brands, Inc. | 537.96M |
| Organogenesis Holdings, Inc. | 287.77M |
| Guardian Pharmacy Services, Inc. | 2.455B |
| Elite Pharmaceuticals, Inc. | 235.70M |
| Daré Bioscience, Inc. | 3.945M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.127M |
| Revenue (Quarterly) | 5.554M |
| Total Expenses (Quarterly) | 6.681M |
| EPS Diluted (Quarterly) | -0.1129 |
| Gross Profit Margin (Quarterly) | 50.03% |
| Profit Margin (Quarterly) | -20.30% |
| Earnings Yield | -85.25% |
| Normalized Earnings Yield | -85.25 |